Antibody purification seems to be safely ensconced in a platform, now well-established by
way of multiple commercialized antibody processes. However, natural evolution compels us …

In recent years, the use of plants as bioreactors has emerged as an exciting area of research
and significant advances have created new opportunities. The driving forces behind the …

Tumour necrosis factor (TNF) is a major pro‐inflammatory cytokine involved in multiple
inflammatory diseases. The detrimental activity of TNF can be blocked by various …

N-glycosylation of a mAb may have a major impact on its therapeutic merits. Here, we
demonstrate that expression of a hybrid enzyme (called xylGalT), consisting of the N …

This comprehensive survey of modern plant breeding traces its history from the earliest
experiments at the dawn of the scientific revolution in the seventeenth century to the present …

Significant advances over the last few years have seen plant-made pharmaceuticals (PMPs)
move from the exploratory research phase towards clinical trials, with the first commercial …

The use of genetically modified (GM) plants to synthesize proteins that are subsequently
processed, regulated and sold as pharmaceuticals challenges two very different established …

Genetically engineered plants can be used for the biomanufacture and delivery of oral
vaccines. Although a myriad of antigens have been produced using this approach …

During the last 25 years, the technology to produce recombinant vaccines in plant cells has
evolved from modest proofs of the concept to viable technologies adopted by some …

Abstract As the United States moves toward a plant-based bioeconomy, a large research
and development effort is focused on creating new feedstocks to meet biomass demand for …